AbbVie (Germany)
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. The company's primary product is Humira, administered via injection. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for AbbVie (Germany), Germany, covering academic research published from 2013 to 2023. Read More.
Open Access Percentage
59%
Total
Publications
910
Total Open
Publications
541
Total
Citations
17K
Open Access
Percentage
59%
Total
Publications
910
Total Open
Publications
541
Total
Citations
17K
Breakdown
Publisher Open
26%
Both
29%
Other Platform Open
4%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
146
Hybrid 32%
159
No Guarantees 39%
197
Other Platform Open
Domain 80%
239
Institution 35%
105
Preprint 10%
29
Other Internet 7%
22
Public 6%
17
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 238 |
Europe PMC | Domain | 120 |
University College London - UCL Discovery | Institution | 23 |
bioRxiv | Preprint | 20 |
KU Leuven - Lirias | Institution | 17 |
Radboud University - Radboud Repository | Institution | 16 |
University of Bristol - Bristol Research | Institution | 12 |
Semantic Scholar | Public | 12 |
Erasmus University Rotterdam - EUR Research Repository | Institution | 11 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 11 |